HM1 Leadership Restructure

The Board has announced the restructure of its leadership, transitioning from a full-time CEO role to a more streamlined model. As a result, Brett Jollie will step down as CEO and Richard Howes will be appointed to a new part-time role of Managing Director.

HM1 Leadership Restructure

May 19, 2025
The Board has announced the restructure of its leadership, transitioning from a full-time CEO role to a more streamlined model. As a result, Brett Jollie will step down as CEO and Richard Howes will be appointed to a new part-time role of Managing Director.
Read Transcript

Hearts & Minds Restructure and Appointment of Richard Howes as Managing Director

The Board of Hearts and Minds Investments Limited (“HM1”; “Hearts & Minds”) has announced the restructure of its leadership, transitioning from a full-time CEO role to a more streamlined model. As a result, Brett Jollie will step down as CEO and Richard Howes will be appointed to a new part-time role of Managing Director.

Richard is a globally experienced executive and director with over 30 years’ experience in the financial services industry. His most recent executive role was as Group CEO of Challenger Limited, an ASX-listed asset manager and retirement income provider.  

Richard Howes will join HM1’s Board and executive team as its Managing Director on 1 June 2025 as well as joining the Investment Committee and Conference Fund Manager Selection Committee.

Since joining HM1 in December 2024, Brett has undertaken a comprehensive review of the business, identifying key opportunities to enhance HM1’s operations and strategic focus.

Under Brett’s leadership, HM1 has:

  • Conducted a thorough review of its operating model
  • Established a new dedicated investment operations function to improve operational efficiency and expertise
  • Implemented an investment management system to automate and improve portfolio management and oversight

These enhancements have significantly improved automation and efficiency and, together with the broader capability in the senior HM1 team, have given the Board the opportunity to evolve its leadership structure, replacing the full-time CEO role with a part-time Managing Director.  

Brett will remain with HM1 until 30 June 2025 to oversee a smooth transition.

Chris Cuffe, Chair of HM1, commented:

On behalf of the Board, I want to sincerely thank Brett for his leadership and the significant contributions he has made in such a short time. His efforts have strengthened HM1, identifying key enhancements that will result in a more efficient, streamlined business with reduced operational risk. Ironically, it is because of these improvements that we are now able to transition to a leaner leadership structure. We greatly appreciate Brett’s impact.

We are delighted to be welcoming Richard to the team. Over his 30-year financial services career, he has successfully managed and grown multi-billion dollar investment portfolios and investment product businesses. I am confident that Richard will help us continue to improve our investment offering and to grow our impact.

The Board will be working closely with Brett and Richard to ensure a smooth transition of leadership.

Brett commented:

I am grateful to the Board for the opportunity to lead HM1 and to contribute to its unique mission. In a short time, we’ve made significant progress in strengthening the business, streamlining operations, and positioning HM1 for the future. I’m confident that these enhancements will support the company’s long-term success and purpose. I want to thank the Board and the HM1 team for their support and collaboration, and I wish them the very best as they continue to add value to shareholders and provide meaningful support to medical research.

Richard commented:

I am honored to be given the responsibility to be the Managing Director of Hearts & Minds which represents both an extraordinary philanthropic success story and a genuine innovation in terms of its investment proposition and process. I am excited to have the opportunity to work with HM1’s outstanding Board and management team to build on this success and to further innovate.

Hearts & Minds Restructure and Appointment of Richard Howes as Managing Director

The Board of Hearts and Minds Investments Limited (“HM1”; “Hearts & Minds”) has announced the restructure of its leadership, transitioning from a full-time CEO role to a more streamlined model. As a result, Brett Jollie will step down as CEO and Richard Howes will be appointed to a new part-time role of Managing Director.

Richard is a globally experienced executive and director with over 30 years’ experience in the financial services industry. His most recent executive role was as Group CEO of Challenger Limited, an ASX-listed asset manager and retirement income provider.  

Richard Howes will join HM1’s Board and executive team as its Managing Director on 1 June 2025 as well as joining the Investment Committee and Conference Fund Manager Selection Committee.

Since joining HM1 in December 2024, Brett has undertaken a comprehensive review of the business, identifying key opportunities to enhance HM1’s operations and strategic focus.

Under Brett’s leadership, HM1 has:

  • Conducted a thorough review of its operating model
  • Established a new dedicated investment operations function to improve operational efficiency and expertise
  • Implemented an investment management system to automate and improve portfolio management and oversight

These enhancements have significantly improved automation and efficiency and, together with the broader capability in the senior HM1 team, have given the Board the opportunity to evolve its leadership structure, replacing the full-time CEO role with a part-time Managing Director.  

Brett will remain with HM1 until 30 June 2025 to oversee a smooth transition.

Chris Cuffe, Chair of HM1, commented:

On behalf of the Board, I want to sincerely thank Brett for his leadership and the significant contributions he has made in such a short time. His efforts have strengthened HM1, identifying key enhancements that will result in a more efficient, streamlined business with reduced operational risk. Ironically, it is because of these improvements that we are now able to transition to a leaner leadership structure. We greatly appreciate Brett’s impact.

We are delighted to be welcoming Richard to the team. Over his 30-year financial services career, he has successfully managed and grown multi-billion dollar investment portfolios and investment product businesses. I am confident that Richard will help us continue to improve our investment offering and to grow our impact.

The Board will be working closely with Brett and Richard to ensure a smooth transition of leadership.

Brett commented:

I am grateful to the Board for the opportunity to lead HM1 and to contribute to its unique mission. In a short time, we’ve made significant progress in strengthening the business, streamlining operations, and positioning HM1 for the future. I’m confident that these enhancements will support the company’s long-term success and purpose. I want to thank the Board and the HM1 team for their support and collaboration, and I wish them the very best as they continue to add value to shareholders and provide meaningful support to medical research.

Richard commented:

I am honored to be given the responsibility to be the Managing Director of Hearts & Minds which represents both an extraordinary philanthropic success story and a genuine innovation in terms of its investment proposition and process. I am excited to have the opportunity to work with HM1’s outstanding Board and management team to build on this success and to further innovate.

Disclaimer: This material has been prepared by Hearts & Minds Investments, published on May 19, 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Guy Fowler & Chris Cuffe. Picture: Adam YipGuy Fowler & Chris Cuffe. Picture: Adam YipGuy Fowler & Chris Cuffe. Picture: Adam YipGuy Fowler & Chris Cuffe. Picture: Adam Yip
January 25, 2024

Fowler toasts Sohn legacy

Grounds, Fowler, and Weiss set up the Australian version, the Sohn Hearts & Minds conference in 2016, with the first meeting at the Sydney Opera House.

Read More
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
December 5, 2023

Guzman y Gomez | Performance Update

Guzman y Gomez (GYG) held its Annual General Meeting on 30 November and provided an update on its FY24 year-to-date results.

Read More
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts
October 3, 2023

Understanding the 4 pillar framework underpinning a high conviction strategy

Listen to episode one with Chief Investment Officer Charlie Lanchester and TDM Growth Partners Investment Team Members Ed Cowan and Fraser Christie. They share their unique investment philosophies and delve into two high conviction stocks recommended for the HM1 portfolio.

Read More
investing
September 5, 2023

Recap on our Australian portfolio holdings

Off the back of reporting season, we have collated some feedback from our Fund Managers on some of the Australian listed companies in the HM1 portfolio.

Read More
April 10, 2023

Introducing our new Chief Investment Officer, Charlie Lanchester

We would like to introduce our new Chief Investment Officer, Charlie Lanchester. Charlie has significant funds management experience and thrilled to be joining the HM1 team.

Read More
November 11, 2022

Sohn Hearts & Minds with Nick Griffin and Maggie O'Neill

Maggie O'Neill, HM1's Head of Marketing and Operations joined Nick Griffin, CIO of Munro Partners to discuss Hearts & Minds' history, Munro Partners' involvement and Nick's upcoming stock pitch.

Read More